Inbal Hazan-Halevy
The Center of Nanoscience and Nanotechnology
Tel Aviv University
Inbal Hazan-Halevy has not added Biography.
If you are Inbal Hazan-Halevy and would like to personalize this page please email our Author Liaison for assistance.
Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2.
Journal of hypertension Jun, 2005 | Pubmed ID: 15894894
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Cancer research Dec, 2007 | Pubmed ID: 18056455
The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Apr, 2009 | Pubmed ID: 19052855
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
Cancer research May, 2009 | Pubmed ID: 19383925
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.
Blood Apr, 2010 | Pubmed ID: 20154216
Kit inhibitor APcK110 extends survival in an AML xenograft mouse model.
Investigational new drugs Oct, 2011 | Pubmed ID: 20517635
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells.
Investigational new drugs Dec, 2011 | Pubmed ID: 20533075
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells.
Molecular cancer research : MCR Apr, 2011 | Pubmed ID: 21364020
Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
Leukemia & lymphoma Sep, 2011 | Pubmed ID: 21649540
The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2012 | Pubmed ID: 22140262
Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
Leukemia & lymphoma Sep, 2012 | Pubmed ID: 22242820
Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
Annals of hematology Aug, 2012 | Pubmed ID: 22349724
Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2013 | Pubmed ID: 23241880
Personalized medicine in CLL: current status and future perspectives.
Cancer letters Sep, 2014 | Pubmed ID: 23879961
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
Blood Jun, 2014 | Pubmed ID: 24778152
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis.
Molecular cancer research : MCR Sep, 2014 | Pubmed ID: 24836891
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.
Cancer letters Aug, 2015 | Pubmed ID: 25933830
Metabolism pathways in chronic lymphocytic leukemia.
Leukemia & lymphoma Apr, 2016 | Pubmed ID: 26643954
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2016 | Pubmed ID: 26699502
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved